New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
Authors
Keywords
-
Journal
Biomolecules
Volume 11, Issue 3, Pages 433
Publisher
MDPI AG
Online
2021-03-15
DOI
10.3390/biom11030433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Parkinson disease, levodopa and the gut microbiota—when microbiology meets pharmacology
- (2020) Harald Brüssow ENVIRONMENTAL MICROBIOLOGY
- Therapeutic microbes to tackle disease
- (2020) Claire Ainsworth NATURE
- Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice
- (2020) Collin Challis et al. NATURE NEUROSCIENCE
- The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
- (2020) Anne-Laure Mahul-Mellier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Probiotic Bacillus subtilis Protects against α-Synuclein Aggregation in C. elegans
- (2020) María Eugenia Goya et al. Cell Reports
- Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems
- (2020) Yu Xu et al. Frontiers in Microbiology
- The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
- (2020) Ygor Parladore Silva et al. Frontiers in Endocrinology
- Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson’s Disease
- (2020) Tobias Hegelmaier et al. Cells
- Transplant of microbiota from long-living people to mice reduces aging-related indices and transfers beneficial bacteria
- (2020) Yinfeng Chen et al. Aging-US
- Gut microbiome signatures of risk and prodromal markers of Parkinson's disease
- (2020) Sebastian Heinzel et al. ANNALS OF NEUROLOGY
- The effect of antibiotics on the gut microbiome: a metagenomics analysis of microbial shift and gut antibiotic resistance in antibiotic treated mice
- (2020) Lei Xu et al. BMC GENOMICS
- Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates
- (2020) Marie-Laure Arotcarena et al. BRAIN
- Interaction between microbiota and immunity in health and disease
- (2020) Danping Zheng et al. CELL RESEARCH
- Developing a new class of engineered live bacterial therapeutics to treat human diseases
- (2020) Mark R. Charbonneau et al. Nature Communications
- Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
- (2020) Mónica Gómez-Benito et al. Frontiers in Pharmacology
- Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease
- (2020) Xin Fang et al. AMB Express
- Can Gut Microbiota Be a Good Predictor for Parkinson’s Disease? A Machine Learning Approach
- (2020) Daniele Pietrucci et al. Brain Sciences
- Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease
- (2020) Tsung-Hsun Hsieh et al. Brain Sciences
- Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
- (2020) Federico Baldini et al. BMC BIOLOGY
- Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson’s disease
- (2020) Jian-Fu Liao et al. BRAIN BEHAVIOR AND IMMUNITY
- Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease
- (2020) Hiroshi Nishiwaki et al. MOVEMENT DISORDERS
- Colonization by Enterobacteriaceae is crucial for acute inflammatory responses in murine small intestine via regulation of corticosterone production
- (2020) Zélia Menezes-Garcia et al. Gut Microbes
- Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
- (2020) Zachary D. Wallen et al. npj Parkinsons Disease
- Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease
- (2020) Yiwei Qian et al. BRAIN
- Probiotic Clostridium Butyricum Ameliorated Motor Deficits in a Mouse Model of Parkinson's Disease via Gut Microbiota-GLP-1 Pathway
- (2020) Jing Sun et al. BRAIN BEHAVIOR AND IMMUNITY
- Fecal microbiota transplantation therapy for Parkinson's disease
- (2020) Liu-Jun Xue et al. MEDICINE
- Mediterranean Dietary Pattern at Middle Age and Risk of Parkinson's Disease: A Swedish Cohort Study
- (2020) Weiyao Yin et al. MOVEMENT DISORDERS
- The gut microbiota–brain axis in behaviour and brain disorders
- (2020) Livia H. Morais et al. NATURE REVIEWS MICROBIOLOGY
- Probiotics for constipation in Parkinson’s disease: A randomized placebo-controlled study
- (2020) Ai Huey Tan et al. NEUROLOGY
- Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
- (2020) Sarah Vascellari et al. mSystems
- Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa‐carbidopa intrajejunal gel
- (2020) Marta Melis et al. EUROPEAN JOURNAL OF NEUROLOGY
- Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model
- (2020) Xiao-Li Dong et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features
- (2020) Fan Zhang et al. PARKINSONISM & RELATED DISORDERS
- Does Gut Microbiota Influence the Course of Parkinson’s Disease? A 3-Year Prospective Exploratory Study in de novo Patients
- (2020) Roberto Cilia et al. Journal of Parkinsons Disease
- Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
- (2020) Hiroshi Nishiwaki et al. mSystems
- The Gut Mycobiome in Parkinson’s Disease
- (2020) Mihai S. Cirstea et al. Journal of Parkinsons Disease
- Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
- (2019) Sebastiaan P. van Kessel et al. Nature Communications
- Brain-Gut-Microbiota Axis in Alzheimer’s Disease
- (2019) Karol Kowalski et al. Journal of Neurogastroenterology and Motility
- Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
- (2019) Marie Therese Fuzzati-Armentero et al. Frontiers in Neurology
- Parkinson's Disease and the Environment
- (2019) Nicole Ball et al. Frontiers in Neurology
- LRRK2 in infection: friend or foe?
- (2019) Susanne Herbst et al. ACS Infectious Diseases
- Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
- (2019) Iria Carballo-Carbajal et al. Nature Communications
- Benefits of Vitamins in the Treatment of Parkinson’s Disease
- (2019) Xiuzhen Zhao et al. Oxidative Medicine and Cellular Longevity
- Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut
- (2019) Nathan Crook et al. Cell Host & Microbe
- The pros, cons, and many unknowns of probiotics
- (2019) Jotham Suez et al. NATURE MEDICINE
- The role of short-chain fatty acids in microbiota–gut–brain communication
- (2019) Boushra Dalile et al. Nature Reviews Gastroenterology & Hepatology
- Neuroprotective benefits of grape seed and skin extract in a mouse model of Parkinson’s disease
- (2019) Sarah Ben Youssef et al. NUTRITIONAL NEUROSCIENCE
- Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis
- (2019) Nannan Li et al. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
- Probiotic Potential and Safety Evaluation of Enterococcus faecalis OB14 and OB15, Isolated From Traditional Tunisian Testouri Cheese and Rigouta, Using Physiological and Genomic Analysis
- (2019) Olfa Baccouri et al. Frontiers in Microbiology
- Akkermansia muciniphila is a promising probiotic
- (2019) Ting Zhang et al. Microbial Biotechnology
- Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats
- (2019) Nathalie Van Den Berge et al. ACTA NEUROPATHOLOGICA
- Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
- (2019) Chin-Hsien Lin et al. Journal of Neuroinflammation
- Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity
- (2019) Sunil Srivastav et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Fecal microbiota transplantation to treat Parkinsonʼs disease with constipation
- (2019) Hongli Huang et al. MEDICINE
- Intestinal infection triggers Parkinson’s disease-like symptoms in Pink1−/− mice
- (2019) Diana Matheoud et al. NATURE
- Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease
- (2019) Sangjune Kim et al. NEURON
- Dysbiosis of gut microbiota in a selected population of Parkinson's patients
- (2019) Daniele Pietrucci et al. PARKINSONISM & RELATED DISORDERS
- Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
- (2019) Vayu Maini Rekdal et al. SCIENCE
- Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota
- (2019) Dae-Wook Kang et al. Scientific Reports
- Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation
- (2019) Jeongho Park et al. Scientific Reports
- Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice
- (2019) Jiayi Zhao et al. Scientific Reports
- Parkinson’s Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation
- (2019) Sudhir K Dutta et al. Journal of Neurogastroenterology and Motility
- Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
- (2019) Chunxiao Li et al. Frontiers in Molecular Neuroscience
- Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence
- (2019) Luca Magistrelli et al. Frontiers in Immunology
- Severe Constipation in Parkinson's Disease and in Parkinsonisms: Prevalence and Affecting Factors
- (2019) Giuseppe Frazzitta et al. Frontiers in Neurology
- Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease
- (2019) Thaisa M. Cantu-Jungles et al. Frontiers in Neurology
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
- (2019) Velma T.E. Aho et al. EBioMedicine
- New Approaches to Microbiome-Based Therapies
- (2019) Andrea C. Wong et al. mSystems
- Role of Dietary Supplements in the Management of Parkinson’s Disease
- (2019) Michele Ciulla et al. Biomolecules
- Probiotics for Parkinson’s Disease
- (2019) Gazerani INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease
- (2019) Fang Li et al. NEUROSCIENCE LETTERS
- Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner
- (2019) Bojan Shutinoski et al. Science Translational Medicine
- In vitro Characterization of Gut Microbiota-Derived Bacterial Strains With Neuroprotective Properties
- (2019) Suaad Ahmed et al. Frontiers in Cellular Neuroscience
- Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson’s Disease: A Systematic Review
- (2019) Jeffrey M. Boertien et al. Journal of Parkinsons Disease
- N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation
- (2019) Corinne Joffre et al. Frontiers in Pharmacology
- Initiation of Parkinson’s disease from gut to brain by δ-secretase
- (2019) Eun Hee Ahn et al. CELL RESEARCH
- B Vitamins and Fatty Acids: What Do They Share with Small Vessel Disease-Related Dementia?
- (2019) Rita Moretti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The gut microbiome in neurological disorders
- (2019) John F Cryan et al. LANCET NEUROLOGY
- Nigral overexpression of α‐synuclein in a rat Parkinson’s disease model indicates alterations in the enteric nervous system and the gut microbiome
- (2019) Sarah M. O’Donovan et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Faecal Transplantation, Pro- and Prebiotics in Parkinson’s Disease; Hope or Hype?
- (2019) T. Van Laar et al. Journal of Parkinsons Disease
- The gut in Parkinson’s disease: Bottom‐up, top‐down, or neither?
- (2019) Laurène Leclair‐Visonneau et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Diet in Parkinson's Disease: Critical Role for the Microbiome
- (2019) Aeja Jackson et al. Frontiers in Neurology
- Microbiome changes: an indicator of Parkinson’s disease?
- (2019) Caroline Haikal et al. Translational Neurodegeneration
- The genetics of Parkinson disease
- (2018) Hao Deng et al. AGEING RESEARCH REVIEWS
- Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway
- (2018) Meng-Fei Sun et al. BRAIN BEHAVIOR AND IMMUNITY
- Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
- (2018) Yiwei Qian et al. BRAIN BEHAVIOR AND IMMUNITY
- The concept of alpha-synuclein as a prion-like protein: ten years after
- (2018) Jennifer A. Steiner et al. CELL AND TISSUE RESEARCH
- The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease
- (2018) Kassem Makki et al. Cell Host & Microbe
- Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial
- (2018) Omid Reza Tamtaji et al. CLINICAL NUTRITION
- The Role of LRRK2 in Neurodegeneration of Parkinson Disease
- (2018) Qin Rui et al. Current Neuropharmacology
- LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages
- (2018) Anetta Härtlova et al. EMBO JOURNAL
- Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells
- (2018) Meng Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mind-altering with the gut: Modulation of the gut-brain axis with probiotics
- (2018) Namhee Kim et al. JOURNAL OF MICROBIOLOGY
- Is Braak staging valid for all types of Parkinson’s disease?
- (2018) Kurt A. Jellinger JOURNAL OF NEURAL TRANSMISSION
- Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease
- (2018) Vincent C. Lombardi et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- The Role of Immunosenescence in Neurodegenerative Diseases
- (2018) Erica Costantini et al. MEDIATORS OF INFLAMMATION
- A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson's disease
- (2018) Agata Mulak MOVEMENT DISORDERS
- Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- (2018) Jose-Alberto Palma et al. MOVEMENT DISORDERS
- Engineering bacteria for diagnostic and therapeutic applications
- (2018) David T. Riglar et al. NATURE REVIEWS MICROBIOLOGY
- Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
- (2018) Fredric P. Manfredsson et al. NEUROBIOLOGY OF DISEASE
- Exploiting the therapeutic potential of ready-to-use drugs: Repurposing antibiotics against amyloid aggregation in neurodegenerative diseases
- (2018) Sergio B. Socias et al. PROGRESS IN NEUROBIOLOGY
- LRRK2 kinase in Parkinson's disease
- (2018) Dario R. Alessi et al. SCIENCE
- Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
- (2018) Sara Gerhardt et al. Nutrients
- The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
- (2018) Bruno Bonaz et al. Frontiers in Neuroscience
- Non-Motor Symptoms of Parkinson’s Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients
- (2018) Houyam Tibar et al. Frontiers in Neurology
- Gut–Brain Axis and Mood Disorder
- (2018) Lu Liu et al. Frontiers in Psychiatry
- Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
- (2018) Mariza Bortolanza et al. JOURNAL OF NEURAL TRANSMISSION
- Gut microbiota in patients with Parkinson's disease in southern China
- (2018) Aiqun Lin et al. PARKINSONISM & RELATED DISORDERS
- The Genus Enterococcus: Between Probiotic Potential and Safety Concerns—An Update
- (2018) Hasna Hanchi et al. Frontiers in Microbiology
- Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota
- (2018) J. Philip Karl et al. Frontiers in Microbiology
- Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
- (2018) Maricel Gómez-Soler et al. Frontiers in Neuroscience
- Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity
- (2018) Tanel Ozdemir et al. Cell Systems
- Role of TLR4 in the gut-brain axis in Parkinson’s disease: a translational study from men to mice
- (2018) Paula Perez-Pardo et al. GUT
- Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease
- (2018) Maria I. Maraki et al. MOVEMENT DISORDERS
- Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
- (2018) Michela Barichella et al. MOVEMENT DISORDERS
- Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation
- (2018) Sara Hernando et al. NEUROBIOLOGY OF DISEASE
- Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox
- (2018) Danielle B. Pedrolli et al. TRENDS IN BIOTECHNOLOGY
- Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis
- (2018) Michaela E. Johnson et al. TRENDS IN NEUROSCIENCES
- The Gut and Parkinson’s Disease: Hype or Hope?
- (2018) Filip Scheperjans et al. Journal of Parkinsons Disease
- Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis
- (2018) Bingxu Huang et al. Frontiers in Immunology
- The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies
- (2017) Paula Perez-Pardo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota
- (2017) Henry Watson et al. GUT
- Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage
- (2017) Isabel Paiva et al. HUMAN MOLECULAR GENETICS
- Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
- (2017) Sudarshan Paramsothy et al. Journal of Crohns & Colitis
- LRRK2 promotes the activation of NLRC4 inflammasome duringSalmonellaTyphimurium infection
- (2017) Weiwei Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Parkinson’s disease as a multisystem disorder
- (2017) Lisa Klingelhoefer et al. JOURNAL OF NEURAL TRANSMISSION
- Epidemiology of Parkinson’s disease
- (2017) Ole-Bjørn Tysnes et al. JOURNAL OF NEURAL TRANSMISSION
- Engineering bacterial thiosulfate and tetrathionate sensors for detecting gut inflammation
- (2017) Kristina N‐M Daeffler et al. Molecular Systems Biology
- REMSleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies
- (2017) Erik K. St Louis et al. MOVEMENT DISORDERS
- Ceftriaxone reduces L -dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model
- (2017) Tanya Chotibut et al. MOVEMENT DISORDERS
- How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology
- (2017) Per Borghammer MOVEMENT DISORDERS
- Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts
- (2017) Fei Yang et al. MOVEMENT DISORDERS
- Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome
- (2017) Erin M. Hill-Burns et al. MOVEMENT DISORDERS
- The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder
- (2017) Anna Heintz-Buschart et al. MOVEMENT DISORDERS
- Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation
- (2017) David T Riglar et al. NATURE BIOTECHNOLOGY
- The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial
- (2017) Mohsen Taghizadeh et al. NEUROCHEMISTRY INTERNATIONAL
- Vagotomy and Parkinson disease
- (2017) Bojing Liu et al. NEUROLOGY
- Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells
- (2017) M.-Y. Son et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Rifampicin inhibits rotenone-induced microglial inflammation via enhancement of autophagy
- (2017) Yanran Liang et al. NEUROTOXICOLOGY
- Motor and Non-Motor Symptoms in Parkinson’s Disease: Effects on Quality of Life
- (2017) Elif GOKCAL et al. Noropsikiyatri Arsivi-Archives of Neuropsychiatry
- Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase
- (2017) Marco Aurélio Mori et al. NUTRITIONAL NEUROSCIENCE
- Role of Diet and Nutritional Supplements in Parkinson’s Disease Progression
- (2017) Laurie K. Mischley et al. Oxidative Medicine and Cellular Longevity
- Gut microbiota: Implications in Parkinson's disease
- (2017) Arun Parashar et al. PARKINSONISM & RELATED DISORDERS
- Novel tactics for neuroprotection in Parkinson's disease: Role of antibiotics, polyphenols and neuropeptides
- (2017) Dora Reglodi et al. PROGRESS IN NEUROBIOLOGY
- Probiotic treatment reduces depressive-like behaviour in rats independently of diet
- (2017) Anders Abildgaard et al. PSYCHONEUROENDOCRINOLOGY
- Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features
- (2017) Wei Li et al. Science China-Life Sciences
- Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
- (2017) et al. Nutrients
- The effects of probiotics on depressive symptoms in humans: a systematic review
- (2017) Caroline J. K. Wallace et al. Annals of General Psychiatry
- Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease
- (2017) Paula Perez-Pardo et al. Frontiers in Aging Neuroscience
- Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients
- (2017) J. R. Bedarf et al. Genome Medicine
- Glucocerebrosidase Mutations in Parkinson Disease
- (2017) Grace O’Regan et al. Journal of Parkinsons Disease
- The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces
- (2017) Donjete Statovci et al. Frontiers in Immunology
- Probiotics and the Gut Immune System: Indirect Regulation
- (2017) Giorgio La Fata et al. Probiotics and Antimicrobial Proteins
- Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function
- (2017) Noora Ottman et al. PLoS One
- Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species
- (2017) Florencia González-Lizárraga et al. Scientific Reports
- Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections
- (2016) Ayse Ulusoy et al. ACTA NEUROPATHOLOGICA
- Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study
- (2016) Toshitaka Odamaki et al. BMC MICROBIOLOGY
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
- (2016) Timothy R. Sampson et al. CELL
- From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
- (2016) Ara Koh et al. CELL
- Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View
- (2016) Roberta Filograna et al. Current Neuropharmacology
- Prebiotics: why definitions matter
- (2016) Robert W Hutkins et al. CURRENT OPINION IN BIOTECHNOLOGY
- Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat
- (2016) John R. Kelly et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Intake of antioxidant vitamins and risk of Parkinson's disease
- (2016) Katherine C. Hughes et al. MOVEMENT DISORDERS
- Mechanisms of inflammation-driven bacterial dysbiosis in the gut
- (2016) M Y Zeng et al. Mucosal Immunology
- Interactions between the microbiota and pathogenic bacteria in the gut
- (2016) Andreas J. Bäumler et al. NATURE
- The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
- (2016) Peter Spanogiannopoulos et al. NATURE REVIEWS MICROBIOLOGY
- Probiotics and prebiotic fiber for constipation associated with Parkinson disease
- (2016) Michela Barichella et al. NEUROLOGY
- Motor symptoms in Parkinson’s disease: A unified framework
- (2016) Ahmed A. Moustafa et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
- (2016) Marcus M. Unger et al. PARKINSONISM & RELATED DISORDERS
- How colonization by microbiota in early life shapes the immune system
- (2016) Thomas Gensollen et al. SCIENCE
- Psychobiotics and the Manipulation of Bacteria–Gut–Brain Signals
- (2016) Amar Sarkar et al. TRENDS IN NEUROSCIENCES
- Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases
- (2016) Heiko Braak et al. Cold Spring Harbor Perspectives in Biology
- The healthy human microbiome
- (2016) Jason Lloyd-Price et al. Genome Medicine
- Effect of Probiotics on Central Nervous System Functions in Animals and Humans: A Systematic Review
- (2016) Huiying Wang et al. Journal of Neurogastroenterology and Motility
- Enhancing NAD+salvage metabolism is neuroprotective in a PINK1 model of Parkinson's disease
- (2016) Susann Lehmann et al. Biology Open
- Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?
- (2016) Doina Georgescu et al. Clinical Interventions in Aging
- Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders
- (2016) Alper Evrensel et al. Clinical Psychopharmacology and Neuroscience
- Anti-inflammatory and immunomodulatory effects of antibiotics and their use in dermatology
- (2016) Bhushan Madke et al. INDIAN JOURNAL OF DERMATOLOGY
- THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
- (2016) Lucrezia Laterza et al. Mediterranean Journal of Hematology and Infectious Diseases
- Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
- (2016) Shu G. Chen et al. Scientific Reports
- Fecal Microbiota Transplantation forClostridium difficileInfection
- (2015) Dimitri Drekonja et al. ANNALS OF INTERNAL MEDICINE
- Vagotomy and subsequent risk of Parkinson's disease
- (2015) Elisabeth Svensson et al. ANNALS OF NEUROLOGY
- Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson’s Disease
- (2015) Daphne Robakis et al. CNS DRUGS
- Neural circuitry and immunity
- (2015) Valentin A. Pavlov et al. IMMUNOLOGIC RESEARCH
- Probiotics, prebiotics and synbiotics- a review
- (2015) Kavita. R. Pandey et al. JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE
- Constipation preceding Parkinson's disease: a systematic review and meta-analysis
- (2015) Kerala L Adams-Carr et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Gastrointestinal dysfunction in Parkinson's disease
- (2015) Alfonso Fasano et al. LANCET NEUROLOGY
- Colonic bacterial composition in Parkinson's disease
- (2015) Ali Keshavarzian et al. MOVEMENT DISORDERS
- Commensal bacteria direct selective cargo sorting to promote symbiosis
- (2015) Qin Zhang et al. NATURE IMMUNOLOGY
- Host microbiota constantly control maturation and function of microglia in the CNS
- (2015) Daniel Erny et al. NATURE NEUROSCIENCE
- Machine learning applications in genetics and genomics
- (2015) Maxwell W. Libbrecht et al. NATURE REVIEWS GENETICS
- Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
- (2015) Lisa Klingelhoefer et al. Nature Reviews Neurology
- Fecal microbiota transplantation broadening its application beyond intestinal disorders
- (2015) Meng-Que Xu WORLD JOURNAL OF GASTROENTEROLOGY
- Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA
- (2015) Simon C. Dyall Frontiers in Aging Neuroscience
- Tyrosine decarboxylase activity of enterococci grown in media with different nutritional potential: tyramine and 2-phenylethylamine accumulation and tyrDC gene expression
- (2015) Eleonora Bargossi et al. Frontiers in Microbiology
- Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?
- (2015) Nazar Mazurak et al. Journal of Neurogastroenterology and Motility
- Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
- (2015) Qinqin Wang et al. Translational Neurodegeneration
- Structural alterations of the intestinal epithelial barrier in Parkinson’s disease
- (2015) Thomas Clairembault et al. Acta Neuropathologica Communications
- Toll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson's Disease
- (2015) J. Drouin-Ouellet et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease
- (2015) Satoru Hasegawa et al. PLoS One
- Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
- (2014) Staffan Holmqvist et al. ACTA NEUROPATHOLOGICA
- Minocycline inhibits ICAD degradation and the NF-κB activation induced by 6-OHDA in PC12 cells
- (2014) Bao-Ping Jiang et al. BRAIN RESEARCH
- You Are What You Host: Microbiome Modulation of the Aging Process
- (2014) Caroline Heintz et al. CELL
- Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers
- (2014) Hemalatha Rajkumar et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Antibiotics and the gut microbiota
- (2014) Sheetal R. Modi et al. JOURNAL OF CLINICAL INVESTIGATION
- Catecholaminergic neurons of mammalian brain and neuromelanin
- (2014) E. G. Sukhorukova et al. JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY
- A Perspective on the Complexity of Dietary Fiber Structures and Their Potential Effect on the Gut Microbiota
- (2014) Bruce R. Hamaker et al. JOURNAL OF MOLECULAR BIOLOGY
- The prevalence of Parkinson's disease: A systematic review and meta-analysis
- (2014) Tamara Pringsheim et al. MOVEMENT DISORDERS
- Gut microbiota are related to Parkinson's disease and clinical phenotype
- (2014) Filip Scheperjans et al. MOVEMENT DISORDERS
- The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
- (2014) Colin Hill et al. Nature Reviews Gastroenterology & Hepatology
- Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats
- (2014) Rohit Bisht et al. NEUROTOXICOLOGY
- Rifampicin Protects PC12 Cells from Rotenone-Induced Cytotoxicity by Activating GRP78 via PERK-eIF2α-ATF4 Pathway
- (2014) Xiuna Jing et al. PLoS One
- The gut microbiota influences blood-brain barrier permeability in mice
- (2014) V. Braniste et al. Science Translational Medicine
- Synthetic Microbes As Drug Delivery Systems
- (2014) Jan Claesen et al. ACS Synthetic Biology
- Ceftriaxone Blocks the Polymerization of α-Synuclein and Exerts Neuroprotective Effects in Vitro
- (2013) Paolo Ruzza et al. ACS Chemical Neuroscience
- Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
- (2013) Ariadna Recasens et al. ANNALS OF NEUROLOGY
- Minocycline: far beyond an antibiotic
- (2013) N Garrido-Mesa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Depression and Parkinson’s Disease: Current Knowledge
- (2013) Laura Marsh Current Neurology and Neuroscience Reports
- Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model
- (2013) Marcio Lazzarini et al. GLIA
- A New Face for Old Antibiotics: Tetracyclines in Treatment of Amyloidoses
- (2013) Tatiana Stoilova et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model
- (2013) Tanya Chotibut et al. MOLECULAR NEUROBIOLOGY
- Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway
- (2013) Kurt Lucas et al. MOLECULAR NEUROBIOLOGY
- The current and projected economic burden of Parkinson's disease in the United States
- (2013) Stacey L. Kowal et al. MOVEMENT DISORDERS
- Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson’s disease
- (2013) R. St. Laurent et al. NEUROSCIENCE
- Autonomic disorders predicting Parkinson's disease
- (2013) Jose-Alberto Palma et al. PARKINSONISM & RELATED DISORDERS
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
- (2013) A. Everard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
- (2013) Lars Brichta et al. TRENDS IN NEUROSCIENCES
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Parkinson's Disease and Parkinsonism: Neuropathology
- (2013) D. W. Dickson Cold Spring Harbor Perspectives in Medicine
- The genetics and neuropathology of Parkinson’s disease
- (2012) Henry Houlden et al. ACTA NEUROPATHOLOGICA
- LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
- (2012) M. S. Moehle et al. JOURNAL OF NEUROSCIENCE
- Neuronal vulnerability, pathogenesis, and Parkinson's disease
- (2012) David Sulzer et al. MOVEMENT DISORDERS
- Human gut microbiome viewed across age and geography
- (2012) Tanya Yatsunenko et al. NATURE
- Techniques used to characterize the gut microbiota: a guide for the clinician
- (2012) Marianne H. Fraher et al. Nature Reviews Gastroenterology & Hepatology
- Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
- (2012) John F. Cryan et al. NATURE REVIEWS NEUROSCIENCE
- Colonic inflammation in Parkinson's disease
- (2012) David Devos et al. NEUROBIOLOGY OF DISEASE
- Rifampicin and Parkinson’s disease
- (2012) Wei Bi et al. NEUROLOGICAL SCIENCES
- n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats
- (2012) Ailing Ji et al. NEUROTOXICOLOGY
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation
- (2012) Peera Hemarajata et al. Therapeutic Advances in Gastroenterology
- Impact of omega-3 fatty acids in Parkinson's disease
- (2011) Mélanie Bousquet et al. AGEING RESEARCH REVIEWS
- Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation
- (2011) Wei Bi et al. BRAIN RESEARCH
- Phenylbutyrate Up-regulates the DJ-1 Protein and Protects Neurons in Cell Culture and in Animal Models of Parkinson Disease
- (2011) Wenbo Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enterotypes of the human gut microbiome
- (2011) Manimozhiyan Arumugam et al. NATURE
- Olfaction in Parkinson's disease and related disorders
- (2011) Richard L. Doty NEUROBIOLOGY OF DISEASE
- Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study
- (2011) Emma Ådén et al. NUTRITIONAL NEUROSCIENCE
- The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal Metagenomes
- (2011) Mark W. J. van Passel et al. PLoS One
- Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
- (2011) Christopher B. Forsyth et al. PLoS One
- Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
- (2011) Roberto Berni Canani WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical progression in Parkinson disease and the neurobiology of axons
- (2010) Hsiao-Chun Cheng et al. ANNALS OF NEUROLOGY
- Prebiotic effects: metabolic and health benefits
- (2010) Marcel Roberfroid et al. BRITISH JOURNAL OF NUTRITION
- Dietary intake of antioxidant vitamins and risk of Parkinson’s disease: a case-control study in Japan
- (2010) Y. Miyake et al. EUROPEAN JOURNAL OF NEUROLOGY
- Short-Chain Fatty Acids Regulate the Enteric Neurons and Control Gastrointestinal Motility in Rats
- (2010) Rodolphe Soret et al. GASTROENTEROLOGY
- The brain to gut pathway: a possible route of prion transmission
- (2010) Victoria A Lawson et al. GUT
- Sleep disturbances in Parkinson's disease
- (2010) Matthew Menza et al. MOVEMENT DISORDERS
- Probiotics and the gut microbiota in intestinal health and disease
- (2010) Mélanie G. Gareau et al. Nature Reviews Gastroenterology & Hepatology
- Composition, variability, and temporal stability of the intestinal microbiota of the elderly
- (2010) M. J. Claesson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers
- (2009) Luying Peng et al. JOURNAL OF NUTRITION
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- Incidence and remaining lifetime risk of Parkinson disease in advanced age
- (2009) J. A. Driver et al. NEUROLOGY
- Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease
- (2009) Ana Marcia Delattre et al. NEUROSCIENCE RESEARCH
- Doxycycline is Neuroprotective Against Nigral Dopaminergic Degeneration by a Dual Mechanism Involving MMP-3
- (2009) Yuri Cho et al. NEUROTOXICITY RESEARCH
- Review: Deep brain stimulation in Parkinson’s disease
- (2009) S.J. Groiss et al. Therapeutic Advances in Neurological Disorders
- A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease
- (2008) CLINICAL NEUROPHARMACOLOGY
- Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism
- (2008) D. W. Anderson et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
- (2008) Garima Dutta et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Depression in Parkinson's disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation
- (2008) Ticyana Moralez da Silva et al. JOURNAL OF AFFECTIVE DISORDERS
- Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
- (2008) Jia-Yi Li et al. NATURE MEDICINE
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
- (2008) H. Sokol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More